Latest Orally disintegrating tablet Stories
MIAMI, Aug. 17, 2011 /PRNewswire/ -- Fuisz Pharma (www.fuisz.com) today announced the publication of U.S. Patent Application US 20110182827 ("Method and Dosage Form to Confirm Compliant Use of a Bioactive Agent").
MISSISSAUGA, Ontario, July 25, 2011 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc.
MIAMI, April 6, 2011 /PRNewswire/ -- Fuisz Pharma LLC announced today a new generation of solid dosage form designs that facilitate swallowing and esophageal transit.
MIAMI, Feb. 7, 2011 /PRNewswire/ -- Based on U.S.
WARREN, N.J. and PORTAGE, Ind., Dec.
MORRISTOWN, N.J., March 17 /PRNewswire/ -- Actavis Group, the international generic pharmaceuticals company, today announced that it has received approval from the U.S. Food & Drug Administration to market Alprazolam orally disintegrating tablets.
WILMINGTON, Del., Aug. 11 /PRNewswire/ -- SPI Pharma, Inc., a leader in oral dispersible tablet (ODT) technologies with its patented Pharmaburst(R) and Pharmafreeze(TM) platforms, recently announced the launch of Pharmaburst(R) 500.
WARREN, N.J., July 23 /PRNewswire/ -- MonoSol Rx, the developers of PharmFilm((R)) technology and a drug delivery company specializing in dissolving thin film pharmaceutical products, today announced the appointment of Theodore "Ted" Clemente, Jr. as Vice President, Business Development. Mr.
SOUTH BRUNSWICK, N.J., July 16 /PRNewswire/ -- Tris Pharma, Inc., a drug delivery and specialty pharmaceutical company, today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S.
WARREN, N.J., June 10 /PRNewswire/ -- MonoSol Rx, the developers of PharmFilm(R) technology and a drug delivery company specializing in dissolving thin film pharmaceutical products, announced today that the new drug application (NDA) for ondansetron orally dissolving film strip (ODFS) has been accepted for review by the U.S.
- To swell, as grain or wood with water.